The present study demonstrates that ANK1 is aberrantly expressed in pancreatic adenocarcinomas in association with promoter hypomethylation and silencing its expression in pancreatic cancer cells is associated with phenotypic changes including decreases in in vivo tumor growth. The gene discussed is ANK1; the disease is familial pancreatic carcinoma.